September 17, 2018
Mountaingate Welcomes New Vice President
DENVER, Colo., September 17, 2018 – Mountaingate Capital (“Mountaingate”), a Denver-based private equity firm employing a proven, buy-and-build strategy that empowers lower middle market companies with strong growth potential and engaged leadership teams, is pleased to announce that Molly Fitzpatrick has joined the firm as Vice President.
“We are excited to welcome Molly to the Mountaingate team. Molly’s wealth of investing experience in the lower middle market and her passionate support of portfolio company management teams will be a great asset to our firm and our culture. Molly’s experience and talents align well with our focus on building enduring partnerships with management teams that drive outstanding outcomes for our investors,” said Bennett Thompson, Managing Director.
Prior to Mountaingate, Molly gained five years of experience investing in the lower middle market at The Halifax Group, a Washington, DC-based private equity firm. Molly started her career as an investment banker at Wachovia and Robert W. Baird working on sell-side advisory deals and equity underwritings. Molly is responsible for identifying, evaluating, and executing investments along with supporting portfolio company management teams in driving growth initiatives.
Molly earned an MBA from Harvard Business School and graduated from the University of Notre Dame where she earned a B.B.A in Finance, magna cum laude. Molly also currently serves on the Young Professionals Board of Moneythink, a financial literacy mentorship program for low income teens.
About Mountaingate Capital
Mountaingate Capital is a private equity firm based in Denver that specializes in building and empowering lower middle market companies with strong growth potential and engaged leadership teams. The firm was launched by a team of partners with deep investment expertise in four distinct market sectors: marketing services, business/industrial services, specialty distribution and specialty manufacturing, including medical devices. Mountaingate’s focus on organic growth coupled with its proven customer-centric buy-and-build approach for add-on acquisitions and shared equity ownership with management creates more value for the end customer, while forging stronger, more collaborative, and more successful investment partnerships with management teams. In 2017, Mountaingate announced the close of its first fund with $395 million in capital commitments. Mountaingate targets investments in new platform companies typically with $5 million to $25 million of EBITDA. For more information on Mountaingate, please visit http://mountaingate.com/.